U.S. equities retreated as soft economic data reinforced fears of a slowdown in early 2025, exacerbated by renewed trade tensions under President Donald Trump. A downbeat tone from corporates added to investor caution, with tech and consumer names under particular pressure.

SNAP -15% | Guidance Withheld on Macro Uncertainty
Snap Inc. plunged after withholding forward guidance, citing macroeconomic headwinds weighing on ad spend visibility. Q1 revenue came in at $1.36B vs est. $1.35B; adj. EPS loss of $0.08 matched expectations. Despite the top-line beat, the lack of outlook unnerved investors.

SMCI -18% | Q3 Prelim Miss Triggers Selloff
Super Micro Computer tumbled after issuing preliminary FQ3 results below consensus. The server maker failed to meet heightened investor expectations amid ongoing supply chain and demand volatility.

SBUX -9% | Soft Q2 Print Undermines Confidence
Starbucks dropped as Q2 adj. EPS of $0.41 missed est. $0.49; revenue of $8.76B vs est. $8.82B. Management flagged weaker-than-expected U.S. traffic, fueling concerns over consumer demand resilience.

CAT +3% | Guidance Reaffirmed Despite Q1 Miss
Caterpillar gained after management reiterated FY targets, helping offset Q1 EPS of $4.25 (vs est. $4.35) and revenue of $14.25B (vs est. $14.66B). Commentary suggested tariff risks were manageable within guidance assumptions.

YUM UNCH | Mixed Q1 Results
Yum Brands was little changed. Q1 revenue of $1.79B missed est. $1.85B, while adj. EPS of $1.30 slightly topped est. $1.29. Management commentary suggested stable same-store sales trends across key brands.

BCS -4% | Volatility Exposure Cited Despite Q1 Beat
Barclays ADRs slid as investors focused on macro commentary despite beats on both top and bottom lines. Pretax profit rose 11% Y/Y. CEO flagged elevated exposure to U.S. market volatility via its investment and consumer banking units.

HUM +5% | EPS Surprise Drives Gains
Humana advanced after delivering Q1 adj. EPS of $11.58, well above est. $10.07. Strong Medicare Advantage performance supported the beat.

GEHC +4% | Q1 Beat, Buyback Boost Sentiment
GE Healthcare rallied after reporting adj. EPS of $1.01 (vs est. $0.91) on revenue of $4.78B (vs est. $4.66B). A newly authorized $1B share repurchase program further buoyed shares.